1,723 trials (keyword fallback)
Kangaroo Care · Video · Prenatal Education
Primary: Intention to Practice Skin-to-skin Contact After Birth — 100; 107; NA; 118 Participants
Skin Toxicities
Primary: Qualitative Data From Patients and Experts to Measure Anti-EGFR Therapy-specific Health-related Quality of Life (HRQL) — 2.70; 2.41; 2.70; 2.29 units on a scale
Carcinoma, Basal Cell · Carcinoma, Squamous Cell · Skin Neoplasms
Primary: The Time to Diagnosis of the First Keratinocyte Carcinoma (KC) on the Face or Ears for Which Surgery is Performed — 3.37; 3.52 years — p=0.93
Dermatitis, Atopic
Primary: Skin Barrier Strengthening Effect by Measurement of Trans Epidermal Water Loss (TEWL) Before and After Induction of Skin Irritation — 19.790; 24.680; 29.648; 28.646 TEWL…
Arthroplasty, Replacement, Hip
Primary: Identification of the Random Initials by the Reviewing Orthopaedic Surgeons — 209; 296 number of correctly identified initals
Lymphoma, Large-Cell, Anaplastic · Enteropathy-Associated T-Cell Lymphoma · Lymphoma, Large B-Cell, Diffuse
Primary: Maximum Tolerated Dose of Anti-Tumor Necrosis Factor (TNF) Receptor Superfamily Member 8 (CD30) Chimeric Antigen Receptor (CAR) in Participants With Advanced…
Nerve; Disorder, Sympathetic
Primary: Time to Indication of Successful Blockade Between the Skin Conductance Numeric Value and Bilateral Thermometry. — 0.08 Seconds
Hypersensitivity
Primary: Cumulative Irritation Total (CIT) Score — 0.0; 20.0; 0.0 Score on a scale
Skin to Skin Contact in Cesarean Deliveries
Primary: Maternal Evoked Pain Scores — 43.55 units on a scale
Xerosis Cutis
Primary: Transepidermal Water Loss (TEWL) in g/m2/h at the Left Mid Volar Forearm — 10.0; 11.9 g/m2/h — p=0.002
Atopic Dermatitis
Primary: Percent Change From Baseline in Transepidermal Water Loss After 5 Skin Tape Stripping (STS) on Lesional Skin (LS) in AD Patients at Week 16 — -54.6 percent change…
Xerosis Cutis
Primary: Change From Baseline in Overall Dry Skin Score (ODS) — -0.9; -1.2; -0.9 units on a scale
Burn, Thermal
Primary: Percent Area of Treatment Sites Requiring Autografting by Month 3 — 4.33; 102.10 percentage of treatment sites — p=<0.0001
Vector Borne Diseases
Primary: Measurement of Change in Early and Late Innate Immune Responses Using Gene Expression and Flow Cytometry in Participants' Skin — 50; 5 % of total dendritic cells
Breastfeeding
Primary: The Median Breast Feeding Score — 8; 9 scores